UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1812-1821

2015

Volltextzugriff (PDF)

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial

Kidney international, 2018-06, Vol.93 (6), p.1475-1482

2018

Volltextzugriff (PDF)

Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5

American journal of nephrology, 2015-04, Vol.41 (2), p.129-137

2015

Volltextzugriff (PDF)

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients

JAMA : the journal of the American Medical Association, 2024-02, Vol.331 (6), p.491

2024

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies

The journal of clinical endocrinology and metabolism, 2019-02, Vol.104 (2), p.550-556

2019

Volltextzugriff (PDF)

Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population‐Based Cohort Study

Journal of bone and mineral research, 2023-05, Vol.38 (5), p.650-658

2023

Volltextzugriff (PDF)

Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis

Nephrology, dialysis, transplantation, 2019-01, Vol.34 (1), p.108-117

2019

Volltextzugriff (PDF)

Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection

Osteoporosis international, 2024-01, Vol.35 (1), p.173-180

2024

Volltextzugriff (PDF)

Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism

The journal of clinical endocrinology and metabolism, 2020-05, Vol.105 (5), p.1581-1588

2020

Volltextzugriff (PDF)

Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency

Osteoporosis international, 2019-01, Vol.30 (1), p.241-249

2019

Volltextzugriff (PDF)

Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature

Swiss medical weekly, 2014-06, Vol.144, p.w13979

2014

Volltextzugriff (PDF)

Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting

Pharmacoepidemiology and drug safety, 2016-11, Vol.25 (11), p.1274-1278

2016

Volltextzugriff (PDF)

Acute hypernatremia and hypocalcemia after oral sodium phosphate administration to a dog

Journal of veterinary internal medicine, 2024-03, Vol.38 (2), p.1157-1159

2024

Volltextzugriff (PDF)

Tolerability of the first infusion of once-yearly zoledronic acid within one to two weeks after hip fracture surgery

Bone (New York, N.Y.), 2022-02, Vol.155, p.116298-116298, Article 116298

2022

Volltextzugriff (PDF)

Fat and Sucrose Intake Induces Obesity‐Related Bone Metabolism Disturbances: Kinetic and Reversibility Studies in Growing and Adult Rats

Journal of bone and mineral research, 2016-01, Vol.31 (1), p.98-115

2016

Volltextzugriff (PDF)

Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation

YAKUGAKU ZASSHI, 2021/08/01, Vol.141(8), pp.1023-1030

2021

Volltextzugriff (PDF)

Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice

PloS one, 2015-09, Vol.10 (9), p.e0138881-e0138881

2015

Volltextzugriff (PDF)

A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2024-01, Vol.22 (Suppl 1), p.342

2024

Volltextzugriff (PDF)

Case report: Recurrent severe hypocalcemia secondary to denosumab in a patient with chronic kidney disease

International journal of rheumatic diseases, 2024-06, Vol.27 (6), p.e15211-n/a

2024

Volltextzugriff (PDF)

Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy

BMJ case reports, 2022-07, Vol.15 (7), p.e250647

2022

Volltextzugriff (PDF)

Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies

Current medical research and opinion, 2013-09, Vol.29 (9), p.1067-1073

2013

Volltextzugriff (PDF)

Identification of the Risk Factors Associated with Hypocalcemia Induced by Denosumab

Biological and Pharmaceutical Bulletin, 2013/10/01, Vol.36(10), pp.1622-1626

2013

Volltextzugriff (PDF)

Osteoporosis Drug Increases Hypocalcemia Risk in Dialysis Patients

The American journal of nursing, 2023-03, Vol.123 (3), p.20-20

Aschenbrenner, Diane S

2023

Volltextzugriff (PDF)

Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?

Osteoporosis international, 2020-04, Vol.31 (4), p.655-665

2020

Volltextzugriff (PDF)

Correlation between high serum alkaline phosphatase levels and denosumab‐related hypocalcemia in patients with multiple myeloma

British journal of haematology, 2019-07, Vol.186 (2), p.355-358

2019

Volltextzugriff (PDF)

1 – 25 von 1.034

Suche als RSS-Feed

Aktive Filter

ThemaHypocalcemia - Etiology

ThemaHypocalcemia - Chemically Induced

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(849)
Mit Volltextzugriff
(642)

Publikationsform

Artikel
(1.033)
magazinearticle
(1)

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(731)
Science & Technology
(707)
Life Sciences & Biomedicine
(695)
Male
(522)
Female
(499)
Animals
(367)
Calcium - Blood
(292)
Middle Aged
(229)
Adult
(205)
Aged
(205)
Biological And Medical Sciences
(180)
Hypocalcemia
(175)
Rats
(174)
Medical Sciences
(163)
Endocrinology & Metabolism
(142)
General & Internal Medicine
(122)
Medicine, General & Internal
(114)
Phosphates - Blood
(103)
Bone Density Conservation Agents - Adverse Effects
(100)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hypocalcaemia in patients with metastatic bone disease treated with denosumab

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial

Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients

Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies

Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population‐Based Cohort Study

Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis

Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection

Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism

Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency

Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature

Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting

Acute hypernatremia and hypocalcemia after oral sodium phosphate administration to a dog

Tolerability of the first infusion of once-yearly zoledronic acid within one to two weeks after hip fracture surgery

Fat and Sucrose Intake Induces Obesity‐Related Bone Metabolism Disturbances: Kinetic and Reversibility Studies in Growing and Adult Rats

Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation

Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice

A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment

Case report: Recurrent severe hypocalcemia secondary to denosumab in a patient with chronic kidney disease

Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy

Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies

Identification of the Risk Factors Associated with Hypocalcemia Induced by Denosumab

Osteoporosis Drug Increases Hypocalcemia Risk in Dialysis Patients

Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?

Correlation between high serum alkaline phosphatase levels and denosumab‐related hypocalcemia in patients with multiple myeloma

Aktive Filter

Suchergebnisse filtern